Actively Recruiting
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Led by Hoffmann-La Roche · Updated on 2026-05-04
300
Participants Needed
17
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
CONDITIONS
Official Title
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed relapsed or refractory diffuse large B-cell lymphoma after one line of systemic therapy
- Treated with or planning to be treated with glofitamab-based regimen within 90 days prior to enrollment
You will not qualify if you...
- Currently participating or planning to participate in any interventional clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Cancer Hospital Chinese Academy of Medical Sciences.
Langfang, Hebei, China, 065001
Actively Recruiting
2
Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center
Tianjin, Tianjin Municipality, China, 301636
Actively Recruiting
3
Peking University People's Hospital
Beijing, China, 100044
Actively Recruiting
4
Peking University Third Hospital
Beijing, China, 100191
Actively Recruiting
5
The First Bethune Hospital of Jilin University
Changchun, China
Actively Recruiting
6
West China Hospital of Sichuan University
Chengdu, China, 610041
Actively Recruiting
7
Guangdong Provincial People's Hospital
Guangzhou, China, 510080
Actively Recruiting
8
Harbin Medical University Cancer Hospital
Harbin, China, 150081
Actively Recruiting
9
Shandong Cancer Hospital
Jinan, China, 250117
Actively Recruiting
10
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China, 200025
Actively Recruiting
11
Tianjin Cancer Hospital
Tianjin, China, 300060
Actively Recruiting
12
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China, 325035
Actively Recruiting
13
Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology
Wuhan, China, 430022
Actively Recruiting
14
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, China, 430030
Actively Recruiting
15
The First Affiliated Hospital of Xian Jiao Tong University
Xi'an, China, 710061
Actively Recruiting
16
Yantai Yu Huangding Hospital
Yantai, China, 264099
Actively Recruiting
17
Henan Cancer Hospital
Zhengzhou, China, 450008
Actively Recruiting
Research Team
R
Reference Study ID Number: ML45172 https://forpatients.roche.com/
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here